Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
29 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Novocure Belgium from Sint-Joost-ten-Node, company number BE0798980387, closed financial year 2025 with a result of € 9,128 after tax. For that financial year Novocure Belgium recorded a gross margin of € 252,907 and equity of € 6,087. Compared with financial year 2024, the result moved from € -8,041 to € 9,128. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 2, 2026.
€ 6,087
▲ € 9,128 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,128
▲ still € 8,041 loss in 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1,087.
People and assets in 2025
0.8
Average over the fiscal year, from the social balance sheet.
€ 233,110
▲ 67% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,356
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 14,025
▼ 62% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,452
▲ 15% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 152,197 | € 252,907 | ▲ 66% |
| Profit after taxes | € -8,041 | € 9,128 | ▲ € 17,170 |
| Equity | € -3,041 | € 6,087 | ▲ € 9,128 |
| Total debts | € 159,570 | € 79,896 | ▼ 50% |
| Cash | € 48,894 | - | |
| Retained profit | € -8,041 | € 1,087 | ▲ € 9,128 |
| Balance sheet total | € 156,528 | € 85,983 | ▼ 45% |
| Employees (FTE) | 0.8 | 0.8 |
Key figures of Novocure Belgium, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Novocure Belgium?
What happened at Novocure Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,128. filed late Source: NBB ↗
- Anne Calixte stepped down as director. NBB
- Thomas Hefti stepped down as director. NBB
- Marco Carrino became a director. NBB
- Pietro Borghi became a director. NBB
- New establishment in Sint-Joost-ten-Node. KBO
- Anette Sander became a director. NBB
- Thomas Hefti became a director. NBB
In short
From € 8,041 loss in 2024 to € 9,128 profit in 2025.
Paid € 5,181 in corporate taxes since 2024.
Best year ever: 2025, with € 9,128 profit.
A new publication or filing at Novocure Belgium? We notify you, reason included.
Follow Novocure BelgiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Novocure Belgium are Marco Carrino, Pietro Borghi and Anette Sander. The shares are held by Novocure GmbH (100%).
Directors
According to the 2025 annual accounts
Marco Carrino
Managing director
since 2025
Pietro Borghi
Director
since 2025
Anette Sander
Director
since 2023
Thomas Hefti
Director
since 2023 · until 2025
Anne Calixte
Director
since 2023 · until 2026
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Kunstlaan 6
1210 Sint-Joost-ten-Node
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 29 companies are registered at this address.
All companies at this address →Arts Lux Real Estate
AMITIE INTERNATIONALE SCOUTE ET GUIDE
CARACAS
€ 108,679 gross margin · 2025
EUROPEAN ASSOCIATION OF CENTRAL CONTERPARTY CLEARING HOUSES
Business Angels Europe
+24 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0798.980.387
- VAT number
- BE 0798.980.387
- Registered office
- Kunstlaan 6, 1210 Sint-Joost-ten-Node
- Names & denominations
- Novocure Belgium
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 March 2023
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied